Table 2.
Correlation between clinicopathological variables and GalNAc-T6 expression
| GalNAc-T6 | ||||
|---|---|---|---|---|
|
| ||||
| Positive n=152 | Negative n=66 | P value | ||
| FIGO stage | Early (I, II) | 117 | 47 | 0.366 |
| Advanced (III, IV) | 35 | 19 | ||
| Grade | 1 and 2 | 139 | 50 | 0.002 |
| 3 | 13 | 16 | ||
| Myometrial invasion | Negative | 30 | 23 | 0.017 |
| Positive | 122 | 43 | ||
| Vascular invasion | Negative | 102 | 40 | 0.356 |
| Positive | 50 | 26 | ||
| Pelvic LN metastasis | Negative | 143 | 58 | 0.118 |
| Positive | 9 | 8 | ||
| Cervical invasion | Negative | 135 | 59 | 0.901 |
| Positive | 17 | 7 | ||
| Ovarian invasion | Negative | 145 | 59 | 0.098 |
| Positive | 7 | 7 | ||
Possitive expression of GalNAc-T6 was significantly associated with low grade of tumors (1 and 2) (P=0.002) and myometrial invasion negative (P=0.017).